Lyra Therapeutics Revenue, Growth & Competitor Profile

DBA 480 BIOMEDICAL, INC.

Company Profile & Annual Report for Lyra Therapeutics

Access the complete profile.

Lyra Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services 541711 Research & Development in Biotechnology
Address	480, Arsenal Street Watertown, MA 02472

Note: Revenues for privately held companies are statistical evaluations.


Lyra Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Lyra Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Lyra Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Lyra Therapeutics Annual Revenue and Growth Rate

Lyra Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Lyra Therapeutics's revenues are gauged from an analysis of company filings.

Lyra Therapeutics's Income Statement (based on Industry Averages)

Lyra Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Lyra Therapeutics is developing and marketing. Lyra Therapeutics doesn't have any recent trademark applications, indicating Lyra Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
STANZA Medical devices, namely, implantable scaffolds comprising of artificial materials for maintaining tissue contour and stents; implantable scaffolds comprising of artificial materials for maintaining tissue contour and stents, with associated coatings and therapeutic agents; drug and biologic delivery systems, for medical and therapeutic use	11/30/2011
480 BIOMEDICAL Medical devices for applying biomaterials for coating, pro-healing, sealing, supporting and separating the surfaces of tissues that can act as barriers, depots for drug delivery, and provide structural scaffolding, namely, implantable medical devices to support and prevent the collapse of surrounding tissue, arteries and veins; stents; catheters; stent delivery system and scaffold delivery system for the placement of implantable scaffolds comprising artificial materials for maintaining tissue contour; medical guidewires	10/06/2011

See all trademarks and details in the Full Report.

Market Share of Lyra Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Lyra Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Lyra Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
REPLIGEN	Waltham, Massachusetts,united States, MA	100
APELLIS PHARMACEUTICALS	Waltham, MA	67
CUBIST PHARMACEUTICALS	Lexington, MA	59
BIOVERATIV U.S. LLC.	Waltham, MA	58
ABCAM	Waltham, MA	29
KARYOPHARM THERAPEUTICS	Newton, MA	25

Future Competition: Lyra Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Lyra Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)